1,087,620 Shares in Prestige Consumer Healthcare Inc. (NYSE:PBH) Bought by Kayne Anderson Rudnick Investment Management LLC

Kayne Anderson Rudnick Investment Management LLC bought a new position in shares of Prestige Consumer Healthcare Inc. (NYSE:PBH) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 1,087,620 shares of the company’s stock, valued at approximately $84,932,000. Kayne Anderson Rudnick Investment Management LLC owned about 2.20% of Prestige Consumer Healthcare as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the company. Vise Technologies Inc. bought a new position in Prestige Consumer Healthcare during the fourth quarter worth $319,000. McIlrath & Eck LLC raised its stake in Prestige Consumer Healthcare by 19.1% during the fourth quarter. McIlrath & Eck LLC now owns 959 shares of the company’s stock worth $75,000 after buying an additional 154 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in Prestige Consumer Healthcare by 24.6% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 118,113 shares of the company’s stock worth $9,223,000 after buying an additional 23,334 shares during the last quarter. Vident Advisory LLC increased its stake in Prestige Consumer Healthcare by 2.8% in the fourth quarter. Vident Advisory LLC now owns 11,254 shares of the company’s stock valued at $879,000 after purchasing an additional 305 shares in the last quarter. Finally, ProShare Advisors LLC increased its stake in Prestige Consumer Healthcare by 44.4% in the fourth quarter. ProShare Advisors LLC now owns 14,925 shares of the company’s stock valued at $1,165,000 after purchasing an additional 4,590 shares in the last quarter. Institutional investors own 99.95% of the company’s stock.

Insider Transactions at Prestige Consumer Healthcare

In other news, SVP Mary Beth Fritz sold 1,678 shares of the business’s stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $90.00, for a total transaction of $151,020.00. Following the completion of the sale, the senior vice president now directly owns 17,157 shares of the company’s stock, valued at $1,544,130. The trade was a 8.91% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.60% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several research firms have weighed in on PBH. Royal Bank of Canada raised shares of Prestige Consumer Healthcare to a “hold” rating in a research note on Thursday, May 8th. Canaccord Genuity Group lifted their price target on shares of Prestige Consumer Healthcare from $93.00 to $100.00 and gave the company a “buy” rating in a research note on Friday, February 7th. DA Davidson lifted their price target on shares of Prestige Consumer Healthcare from $95.00 to $104.00 and gave the company a “buy” rating in a research note on Friday, February 7th. Wall Street Zen raised shares of Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research note on Saturday, May 17th. Finally, Oppenheimer lifted their price target on shares of Prestige Consumer Healthcare from $87.00 to $93.00 and gave the company an “outperform” rating in a research note on Thursday, February 13th. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $93.33.

Prestige Consumer Healthcare Trading Up 1.1%

NYSE:PBH opened at $85.98 on Friday. The company has a debt-to-equity ratio of 0.56, a current ratio of 3.68 and a quick ratio of 2.20. The firm has a 50-day moving average of $83.52 and a 200-day moving average of $82.28. The company has a market cap of $4.25 billion, a PE ratio of 20.14, a PEG ratio of 2.69 and a beta of 0.44. Prestige Consumer Healthcare Inc. has a one year low of $62.35 and a one year high of $90.04.

Prestige Consumer Healthcare (NYSE:PBH) last posted its earnings results on Thursday, May 8th. The company reported $1.32 EPS for the quarter, topping the consensus estimate of $1.30 by $0.02. The company had revenue of $296.52 million during the quarter, compared to the consensus estimate of $289.36 million. Prestige Consumer Healthcare had a net margin of 19.13% and a return on equity of 12.36%. The firm’s revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the firm posted $1.02 earnings per share. As a group, equities research analysts expect that Prestige Consumer Healthcare Inc. will post 4.5 EPS for the current fiscal year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.